FUNDAMENTAL AND MODERN RESEARCHES IN SEPSIS BASED ON INTERDISCIPLINARY APPROACHES

Life-threatening organ malfunction brought on by an infection is known as sepsis. Considered a hidden public health disease, sepsis continues to be the greatest cause of death not just in intensive care units (ICUs) but also in all age categories globally. To improve outcomes, early diagnosis and recognition are essential. Sepsis's intricate pathophysiology leads to the release of several biomarkers. More biomarkers can be used to monitor the host's reaction to the infection, which could help clinicians treating these individuals. Since it might be challenging to distinguish sepsis from non-infectious systemic inflammatory response syndrome, one of medicine's main goals is to find a highly reliable biomarker of sepsis. Our special issue aims to provide an overview of the most current developments concerning the most often researched blood biomarkers, as assessed in clinical and experimental trials, for the purpose of early sepsis diagnosis as well as their informative value in diagnosis, prognosis, or treatment response. Since it might be challenging to distinguish sepsis from non-infectious systemic inflammatory response syndrome, one of medicine's main goals is to find a highly reliable biomarker of sepsis. Our special issue aims to provide an overview of the most current developments concerning the most often researched blood biomarkers, as assessed in clinical and experimental trials, for the purpose of early sepsis diagnosis as well as their informative value in diagnosis, prognosis, or treatment response.

Submission deadline: 10/10/2024